Technical Description
The invention introduces a plant-based synthesis of a biocompatible, amphiphilic carbon nanomaterial with antiangiogenic and anti-tumor activity from arginine metabolism.
Problems Addressed
- Low Yield Rates
- Complex Synthesis
- Poor Product Quality
- Limited Mechanical Strength
Tech Features
- Anti-tumor Activity
- High Quantum Yield
- Enhanced Crystallinity
- Eco-Friendly
- Cost-Effective
Target Audience
- Pharmaceutical Industry
- Drug Delivery System
- Food and Beverage Industry
- Cosmetic Industry
Tech ID: P26-1998 TRL 4 Patent Status: Published Available For Exclusive and Non-exclusive License
